Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?May 7, 2024Patient & Survivor CareMixed TopicsDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Terminal Cancer: What Matters to Patients and CaregiversMay 7, 2024Patient & Survivor CareDLBCLMixed TopicsAggressive LymphomasALLAMLB Cell Lymphoma
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Patient & Survivor CarePediatricsDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Keratoacanthoma, SCC Relatively Rare With PD-1/PD-L1 Inhibitors, Study SuggestsApril 22, 2024Mixed Topics
Adding ACEI to Chemotherapy Does Not Prevent CardiotoxicityApril 19, 2024Patient & Survivor CareMixed TopicsNon-Hodgkin Lymphoma
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024DLBCLGene TherapyPatient & Survivor CarePediatricsMixed TopicsBusiness of MedicineALL
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024DLBCLPatient & Survivor CarePediatricsMixed TopicsALLAggressive LymphomasB Cell Lymphoma
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLB Cell Lymphoma
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Patient & Survivor CareOpioid Resource CenterFast Facts FridayDLBCLMixed TopicsAggressive LymphomasALL
Blood Cancer Emergencies: Hematologists’ Late-Night CallsApril 3, 2024Mixed TopicsAMLCLLALLNon-Hodgkin LymphomaCML
A Banned Chemical That Is Still Causing CancerApril 3, 2024DLBCLPatient & Survivor CareMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Patient & Survivor CareAggressive LymphomasALLAMLB Cell LymphomaCLLCML
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasALLAML
Secondary Cancers Post CAR T Therapy: A Concern?March 20, 2024Cellular TherapyAggressive LymphomasALLAMLAnemiaCLLCML
